ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/12/29 | 2,251 | 2,284 | 2,237 | 2,281 | +30 | +1.3% | 40,700 |
2022/12/28 | 2,237 | 2,253 | 2,226 | 2,251 | +5 | +0.2% | 38,100 |
2022/12/27 | 2,235 | 2,258 | 2,225 | 2,246 | +15 | +0.7% | 24,000 |
2022/12/26 | 2,254 | 2,254 | 2,227 | 2,231 | -15 | -0.7% | 16,900 |
2022/12/23 | 2,247 | 2,261 | 2,232 | 2,246 | -13 | -0.6% | 26,500 |
2022/12/22 | 2,247 | 2,269 | 2,237 | 2,259 | +22 | +1% | 42,400 |
2022/12/21 | 2,247 | 2,258 | 2,219 | 2,237 | -19 | -0.8% | 55,100 |
2022/12/20 | 2,284 | 2,299 | 2,193 | 2,256 | -21 | -0.9% | 53,600 |
2022/12/19 | 2,264 | 2,284 | 2,258 | 2,277 | +17 | +0.8% | 44,900 |
2022/12/16 | 2,300 | 2,309 | 2,260 | 2,260 | -42 | -1.8% | 112,400 |
2022/12/15 | 2,314 | 2,340 | 2,300 | 2,302 | -26 | -1.1% | 26,000 |
2022/12/14 | 2,300 | 2,334 | 2,293 | 2,328 | +34 | +1.5% | 83,000 |
2022/12/13 | 2,270 | 2,303 | 2,269 | 2,294 | +48 | +2.1% | 70,600 |
2022/12/12 | 2,219 | 2,253 | 2,211 | 2,246 | +3 | +0.1% | 33,500 |
2022/12/09 | 2,238 | 2,251 | 2,230 | 2,243 | ±0 | ±0% | 37,500 |
2022/12/08 | 2,223 | 2,249 | 2,213 | 2,243 | +27 | +1.2% | 64,400 |
2022/12/07 | 2,189 | 2,230 | 2,184 | 2,216 | +25 | +1.1% | 33,700 |
2022/12/06 | 2,155 | 2,200 | 2,155 | 2,191 | +8 | +0.4% | 44,700 |
2022/12/05 | 2,203 | 2,206 | 2,169 | 2,183 | -27 | -1.2% | 34,400 |
2022/12/02 | 2,240 | 2,247 | 2,192 | 2,210 | -48 | -2.1% | 78,900 |
2022/12/01 | 2,227 | 2,260 | 2,226 | 2,258 | +32 | +1.4% | 69,300 |
2022/11/30 | 2,242 | 2,245 | 2,224 | 2,226 | -16 | -0.7% | 50,400 |
2022/11/29 | 2,268 | 2,269 | 2,240 | 2,242 | -43 | -1.9% | 64,500 |
2022/11/28 | 2,295 | 2,297 | 2,268 | 2,285 | +6 | +0.3% | 37,500 |
2022/11/25 | 2,274 | 2,291 | 2,274 | 2,279 | +23 | +1% | 39,800 |
2022/11/24 | 2,266 | 2,280 | 2,255 | 2,256 | -7 | -0.3% | 52,700 |
2022/11/22 | 2,220 | 2,266 | 2,220 | 2,263 | +49 | +2.2% | 72,600 |
2022/11/21 | 2,200 | 2,221 | 2,195 | 2,214 | +23 | +1% | 41,700 |
2022/11/18 | 2,200 | 2,210 | 2,191 | 2,191 | -7 | -0.3% | 61,500 |
2022/11/17 | 2,163 | 2,199 | 2,163 | 2,198 | +31 | +1.4% | 39,900 |
2022/11/16 | 2,150 | 2,178 | 2,145 | 2,167 | +17 | +0.8% | 53,000 |
2022/11/15 | 2,162 | 2,169 | 2,150 | 2,150 | +13 | +0.6% | 28,000 |
2022/11/14 | 2,170 | 2,174 | 2,135 | 2,137 | -61 | -2.8% | 48,700 |
2022/11/11 | 2,223 | 2,225 | 2,183 | 2,198 | +5 | +0.2% | 45,200 |
2022/11/10 | 2,187 | 2,208 | 2,185 | 2,193 | -16 | -0.7% | 31,200 |
2022/11/09 | 2,220 | 2,228 | 2,197 | 2,209 | -18 | -0.8% | 44,800 |
2022/11/08 | 2,199 | 2,234 | 2,194 | 2,227 | +35 | +1.6% | 65,000 |
2022/11/07 | 2,192 | 2,199 | 2,171 | 2,192 | ±0 | ±0% | 86,200 |
2022/11/04 | 2,214 | 2,214 | 2,165 | 2,192 | -22 | -1% | 135,100 |
2022/11/02 | 2,194 | 2,245 | 2,194 | 2,214 | +50 | +2.3% | 166,000 |
2022/11/01 | 2,220 | 2,220 | 2,157 | 2,164 | -53 | -2.4% | 100,800 |
2022/10/31 | 2,195 | 2,234 | 2,172 | 2,217 | +61 | +2.8% | 191,000 |
2022/10/28 | 2,131 | 2,158 | 2,119 | 2,156 | -19 | -0.9% | 683,700 |
2022/10/27 | 2,178 | 2,191 | 2,156 | 2,175 | -3 | -0.1% | 116,000 |
2022/10/26 | 2,147 | 2,193 | 2,147 | 2,178 | +31 | +1.4% | 92,400 |
2022/10/25 | 2,130 | 2,156 | 2,130 | 2,147 | +18 | +0.8% | 67,800 |
2022/10/24 | 2,147 | 2,158 | 2,128 | 2,129 | +4 | +0.2% | 70,800 |
2022/10/21 | 2,122 | 2,143 | 2,116 | 2,125 | -9 | -0.4% | 45,800 |
2022/10/20 | 2,126 | 2,138 | 2,116 | 2,134 | -23 | -1.1% | 55,400 |
2022/10/19 | 2,141 | 2,159 | 2,123 | 2,157 | +10 | +0.5% | 74,900 |
651~
700
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,500円 | -2.4% | -52.3% | 3.74% | 18.25倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム